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Purpose: Endothelial cells produce many biologically important factors that may be used 
as functional markers, including plasminogen activators and their inhibitors (PAI). 
PAI-1 is a common peptide with a central role in the balance of thrombosis and 
fibrinolysis in vivo, and its production by vascular endothelial cells has been demon- 
strated for many in vitro cell lines. 
Methods: The basal rate of PAI-1 release from cultured human adult endothelial cells was 
studied in both a well-plate-seeding model and after seeding onto human endarterectomy 
specimens. The effect of nonspecific stimulation with thrombin on PAL1 release was 
examined in well-plate cultures. PAI-1 was measured by enzyme-linked immunosorbent 
assay. 
Results'. Cultured human saphenous endothelial cells release PAI-1 constitutively at a 
steady rate, which can be increased in the short term by the addition of thrombin. 
Conclusion: After seeding onto endarterectomy specimens, eeded endothelial cells release 
significant amounts of PAI-I, which suggests that they retain functional integrity and 
may potentially influence thrombosis n vivo after seeding. (J Vasc Surg 1997;25:722-5.) 
The production of  plasminogen activator inhibi- 
tor- 1 (PAI-1) has been previously described for cul- 
tured vascular endothelial cells derived from a variety 
of  human and animal origins. In seeding practice, 
human adult endothelial cells (HAECs) taken from 
saphenous vein are the most appropriate to the clin- 
ical situation. Seeding of the native tissue surfaces 
might be expected to overcome many of the difficul- 
ties that are experienced with prosthetic graft seed- 
ing, but cells must retain functional integrity to be 
effective. We therefore investigated the potential of 
HAECs to produce this biologically important pep- 
tide as a functional marker in in vitro cell culture and 
after in vitro seeding onto heterologous human end- 
arterectomy specimens. 
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MATERIALS AND METHODS 
This study was performed with local ethical com- 
mittee approval and informed patient consent. 
HAECs were enzymatically harvested with collage- 
nase from segments of long saphenous vein from 
patients undergoing varicose vein or peripheral arte- 
rial surgery. Cells were cultured to a maximum of 
second passage in complete medium (CM; medium- 
199 with Earle's salts and 20 mmol /L  Hepes buffer, 
L-glutamine 2 mmol/ml,  heparin 100 U/ml ,  endo- 
thelial cell growth factor 0.03 mg/ml ,  gentamicin 
0.04 mg/ml,  20% fetal calf serum). We have previ- 
ously used this technique xtensively to produce pure 
endothelial cultures using surface markers and cul- 
ture morphologic appearances. 
Constitutive production. Cultured HAECs 
from confluent culture were seeded into 24-well 
plates at 50,000 cells/well and grown to confluence. 
Well plates were then washed with serum-free me- 
dium (SFM), and reincubated in fresh SFM. At 15, 
30, and 45 minutes and 1, 2, 4, 8, 16, and 24 hours, 
the conditioned medium was removed from 10 
wells, and the appearance of the cells was examined 
microscopically. Samples of  conditioned medium 
were immediately frozen at -70 ° C until assay. 
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Fig. 1. Twenty-four hour production of PAI-1 by unstimulated HAECs cultured in well- 
plates. Error bars, SEM around the mean. 
Inducible production. In separate xperiments 
using the same methods, HAECs were reincubated 
in SFM containing 1 U/ml  thrombin, a nonspecific 
stimulant of endothelial cells. After removal of con- 
ditioned medium, well-plate cultures were examined 
by light microscopy to confirm healthy culture, using 
morphologic appearances. 
Endarterectomy seeding. Specimens of superfi- 
cial femoral artery in patients undergoing bypass for 
complete occlusion were endarterectomized in situ, 
removed, and directly transferred to the cell culture 
laboratory in buffered saline solution at 4 ° C. Heter- 
ologous HAECs, as described above, were seeded 
onto 1 cm 2 discs in seeding chambers at a densit 3,of 
2 X 10 s cells/cm and incubated for 1 hour. Excess 
seeding solution and unattached cells were aspirated 
and the seeded discs cultured for 72 hours in CM, 
which was renewed at 36 hours. This technique has 
been previously demonstrated to produce endothe- 
lial monolayers using endothelial-specific staining. 1 
At 72 hours, the CM was replaced by SFM, and 
the cultures were returned to the incubator for a 
further 20 hours, when the conditioned medium was 
removed and frozen at -70 ° C until assay. Unseeded 
endarterectomy specimens erved as controls. After 
culture, endarterectomy specimens were preserved in 
glutaraldehyde/cacodylate buffer for examination 
by environmental scanning electron microscopy 
(ESEM). 
PAI-1 assay. Samples were analyzed using the 
Tint-Elize PAId kit (Biopool AB, Umea, Sweden) 
and a polyclonal conjugate. Plates were read by auto- 
mated plate reader at 490 nm. PAI- 1 production was 
calculated per cm 2 of culture area to allow compari- 
son between well-plate and seeded endarterectomy 
cultures. 
Statistics. Group medians were compared using 
95% confidence limits (Confidence Interval Analysis 
software). 
RESULTS 
PAI- 1 antigen was easily detected in all specimens 
except two of the control endarterectomy experi- 
ments, which were therefore xcluded from analysis. 
Phase contrast microscopy confirmed all well-plate cul- 
tures to be healthy, confluent, and free of smooth 
muscle contamination at the time of medium sampling. 
Well-plate culture. HAECs showed constitu- 
tive production of PAI-1 antigen consistent with 
first-order kinetics (correlation 0.997) of approxi- 
mately 2.68 ng/cm2/hr  (Fig. 1). The addition of 
thrombin to the SFM resulted in an initial accelera- 
tion in PAI-1 release by the endothelial cells, which 
then returned to the level of constitutive release for 
the remainder of the experiment. These differences 
were small but statistically significant between t o and 
t 4 (95% confidence limits of the difference in medians 
excluding 0). 
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Fig. 2. Comparison of PAI-1 production between well- 
plate cultures (n = 10), HAECs seeded onto endarterec- 
tomy specimens (n = 10), and control endarterectomy 
specimens (n = 6). Incubation time 20 hours. Arrows 
indicate specimens where endothelialization was poor by 
ESEM analysis. Error bars, SEM around the mean. Data 
points are for individual experiments. 
Endarterectomy culture. The median (mean + 
SEM) production of PAl-1 antigen from endothelial 
cell cultures on endarterectomy specimens was 42.2 
ng/cm 2 (43.1 + 1.4), significantly greater than well- 
plate production, 36.2 ng/cm 2 (34.8 + 2.2), ex- 
cluding two experiments where seeding failed to pro- 
duce significant endothelial coverage when examined 
by ESEM (Fig. 2). In these, PAl-1 production was 
similar to control, unseeded endarterectomy speci- 
mens. 
The median PAl-1 production in control experi- 
ments was 30.5 ng/cm 2 (31.5 + 3.0), significantly 
less than by seeded endarterectomy specimens (95% 
confidence limits of the difference in medians). The 
close agreement between means and medians ug- 
gests a normal distribution of PAl-1 production in 
this heterogenous group of cell culture lines, which 
may arise in part from variations in cell numbers 
retained after seeding. 
DISCUSSION 
Plasminogen activators and their inhibitors 
(PAls) are important functional products of endo- 
thelial cells and mediators of thrombosis and fibrino- 
lysis, 2,3 of which PAl-1 is the most important physi- 
ologically. 4 PAl-1 has been shown to be released by 
endothelial cells of several origins 5-7 including 
HAECs, 8 as well as human vascular smooth muscle 
cells in culture. 9 Human aortic endothelium and 
smooth muscle have also been shown to express 
PAI-1 in vivo. l°,H The rate of PAI-1 production is 
affected by the nature of the surface on which the 
cells are cultured in vitro x2,~3 as well as exposure to 
factors uch as endotoxin, 14 tumor necrosis factor, ~s 
endothelin, 16thrombin, lz protein C, ~s and oxidized 
low-density lipoproteins. 19PAI-1 is systemically re- 
leased as part of the acute phase response to all types 
of cell injury, such as hypoxia, reperfusion, or endo- 
toxemia, 2° and most of this is thought o be derived 
from vascular endothelium.lS The use of biologically 
active cell products to assess cell function has been 
extensively used previously. 21,2e 
In clinical practice, the use of endothelial cells for 
seeding is limited by the availability of adequate cell 
numbers, and the most common source is autolo- 
gous long saphenous vein endothelium, z3 These re- 
suhs confirm the findings of ZoeUner et al.s that 
HAECs in culture produce PAI-1 at a steady rate 
comparable with other endothelial cell lines. In addi- 
tion, thrombin stimulates PAl-1 in the short term, 
which suggests a direct effect on stored PAI-1 rather 
than an induction of protein synthesis. Cell-associ- 
ated PAI-1, in contrast o PAI-2, is known to be 
limited, which may account for the moderate re- 
sponse to stimulation. 
Endothelial seeding of native vessels after both 
endarterectomy and angioplasty has been successful 
in animals, with retention of seeded-cell function. 
We have previously described the development ofan 
endothelial monolayer on human endarterectomy 
specimens invitro, ~ but for this to be effective in vivo 
the seeded cells must retain functional integrity. Us- 
ing PAI-1 as a marker, where seeding successfully 
produces ignificant endothelialization, the seeded 
cells retain functional integrity. Christ et al.~3 
showed down-regulation of PAI-1 production by 
human umbilical vein endothelial cells (HUVECs) in 
vitro using SMC-conditioned media, and this may 
account for the difference in production between 
well-plate culture and seeded cells where the excess 
PAl-1 in seeded endarterectomy specimens is less 
than might be predicted. Alternatively, this may re- 
flect modulation of the SMC production ofPAI-1 by 
the endothelial monolayer, in a similar way to mito- 
genesis. 24 Possibly, there is mutual downgrading of 
PAl-1 production, resulting in total output less than 
the summation of the individual responses. As has 
previously been noted, there is a range of PAl-1 
production that reflects the multiple cell lines used. s
This appears to follow a normal distribution, and 
may be genetic or acquired, related to factors uch as 
age, sex, smoking status, or serum lipid levels. 
Although elevated PAI-1 production is theoreti- 
cally thrombogenic and thus undesirable, in vivo the 
balance of thrombosis-fibrinolysis i  also influenced 
by other factors uch as plasminogen activators. Reg- 
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ulation of the endothelial production of both pro- 
thrombotic and antithrombotic factors is complex 
and is not fully understood; the in vitro model serves 
only as a guide to interactions between endothelial 
cells and stimuli. Thus, in these experiments, the 
levels of PAL 1 production act as a general marker of 
cell function in a similar way to prostacyclin produc- 
tion and suggest that the seeded cells retain the 
capacity to function normally when cultured on end- 
arterectomy specimens. 
The authors would like to thank Elsa Eriksson of  Uni- 
versity Hospital, GSteborg, Sweden, for assistance with the 
initial PAL1 assays. 
REFERENCES 
1. Smyth JV, Rooney OB, Dodd PDF, Walker MG. Culture of 
human endothelial cells on endarterectomy surfaces. Eur J 
Vasc Endovasc Surg 1995;10:308-15. 
2. Schleef RR, Loskutoff DJ. Fibrinolytic system of vascular 
endothelial cells: role of plasminogen activator inhibitors. 
Haemostasis 1988;18:328-41. 
3. Loskutoff DJ, Ny T, Sawdey M, Lawrence D. Fibrinolytic 
system of cultured endothelial cells: regulation by plasmino- 
gen activator inhibitor. J Cell Biochem 1986;32:273-80. 
4. Kruithof EKO. Plasminogen activator inhibitor type 1: bio- 
chemical, biological and clinical aspects. Fibrinolysis 1988;2: 
59-70. 
5. Speiser W, Anders E, Binder BR, Muller-Berghaus G. Clot 
lysis mediated by cultured human microvascular endothelial 
cells. Thromb Haemost 1988;60:463-7. 
6. van Hinsbergh VWM, Binnema D, Scheffer MA, Sprengers 
ED, Kooistra T, Rijken DC. Production ofplasminogen acti- 
vators and inhibitor by serially propagated endothelial cells 
from adult human blood vessels. Arteriosclerosis 1987;7:389- 
400. 
7. van Hinsbergh VWM, Spengers ED, Kooistra T. Effect of 
thrombin on the production of plasminogen activators and 
plasminogen activator inhibitor-1 by human foreskin micro- 
vascular endothelial cells. Thromb Haemost 1987;57:148- 
53. 
8. Zoellner H, Wojta J, Gallicchio M, McGrath K, Hamilton JA. 
Cytokine regulation of the synthesis ofplasminogen activator 
inhibitor-2 by human vascular endothelial cells. Thromb Hae- 
most 1993;69:135-40. 
9. Wojta J, Gallicchio M, Zoellner H, Hufnagi P, Last K, Filonzi 
E, et al. Thrombin stimulates expression of tissue-type plas- 
minogen activator and plasminogen activator inhibitor type 1 
in cultured human vascular smooth muscle cells. Thromb 
Haemost 1993;70:469-74. 
10. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, 
Bachmann F, et al. Localization and production of plasmino- 
gen activator inhibitor-1 in human healthy and atheroscle- 
rotic arteries. Arterioscler Thromb Vase Biol 1993;13:1090- 
100. 
11. Schneiderman J, Sawdey MS, Keeton MR, Bardin GM, Bern- 
stein EF, Dilley RB, et al. Increased type 1 plasminogen 
activator inhibitor gene expression in atherosclerotic human 
arteries. Proc Natl Acad Sci U S A 1992;89:6998-7002. 
12. Li J-M, Menconi MJ, Wheeler HB, Rohrer MJ, Klassen VA, 
Ansell JE, Appel MC. Precoating expanded polytetrafluoro- 
ethylene grafts alters production of endothelial cell-derived 
thrombomodulators. J Vasc Surg 1992;15:1010-7. 
13. Christ G, Seiffert D, Hufnagl P, Gessl A, Wojta J, Binder BR. 
Type 1 plasminogen activator inhibitor synthesis of endothe- 
lial cells is downregulated by smooth muscle cells. Blood 
1993;81:1277-83. 
14. Hanss M, Collen D. Secretion of tissue-type plasminogen 
activator and plasminogen activator inhibitor by cultured hu- 
man endothelial cells: modulation by thrombin, endotoxin 
and histamine. J Lab Clin Med 1987;109:97-104. 
15. van Hinsbergh VWM, Kooistra T, van den Berg EA, Princen 
HMG, Fiers W, Emeis JJ. Tumor necrosis factor increases the 
production of plasminogen activator inhibitor in human en- 
dothelial cells in vitro and in rats in vivo. Blood 1988;72: 
1467-73. 
16. Yamamoto C, Kaji T, Sakamoto M, Koizumi F. Effect of 
endothelin on the release of tissue plasminogen activator and 
plasminogen activator inhibitor-1 from cultured human en- 
dothelial cells and interaction with thrombin. Thromb Res 
1992;67:619-24. 
17. Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of 
plasminogen activator-inhibitor in cultured human endothe- 
lial cells. J Clin Invest 1986;77:165-9. 
18. van Hinsbergh VWM, Bertina RM, van Wijngaarden A, van 
Tilburg NH, Emeis JJ, Haverkate F. Activated protein C 
decreases plasminogen activator inhibitor activity in endothe- 
lial cell-conditioned medium. Blood 1985;65:444-51. 
19. Kugiyama K, Sakamoto T, Misumi I, Sugiyama S, Ohgushi 
M, Ogawa H, et al. Transferable lipids in oxidized low- 
density lipoprotein stimulate plasminogen activator inhibi- 
tor-1 and inhibit tissue-type plasminogen activator elease 
from endothelial cells. Circ Res 1993;73:335-43. 
20. Welch M, Douglas JT, Smyth JV, Walker MG. Systemic 
endotoxaemia and fibrinolysis during aortic surgery. Eur J 
Vasc Endovasc Surg 1995;9:228-32. 
21. Bush HL, Jakubowski JA, Curl GR, Deykin D. Luminal 
healing of arterial endarterectomy: role of autogenous endo- 
thelial cell seeding. Surg Forum 1985;36:446-50. 
22. Sicard GA, Allen BT, Long JA, Welch MJ, Griffin A, Clark 
RE, Anderson CB. Prostaglandin production and platelet 
reactivity of small diameter grafts. J Vasc Surg 1984;1:774- 
81. 
23. Welch M, Durrans D, Carr HMH, Vohra R, Rooney OB, 
Walker MG. Endothelial cell seeding: areview. Ann Vasc Surg 
1992;6:473-84. 
24. Scott-Burden T, Vanhoutte PM. Regulation of smooth mus- 
cle cell growt, h by endothelium-derived growth factors. Tex 
Heart Inst J 1994;21:91-7. 
Submitted May 28, 1996; accepted Oct. 17, 1996. 
